DermTech Inc. Accused of Deceptive Practices in Pigmented Lesion Assessment Test: A Call to Action for Affected Consumers"

As a consumer harm journalist, it is my duty to expose companies that engage in deceptive practices, putting profits over people's well-being. Recently, I came across a class action lawsuit filed against DermTech Inc. and others, which raises serious concerns about the company's Pigmented Lesion Assessment (PLA) test. The lawsuit, Quarford v. DermTech Inc., et al. (case no. 23-02221), alleges false advertising, misrepresentation, breaches of contract, and violations of consumer protection laws. In this article, I will provide an overview of the case and explain why it's essential for affected consumers to take action.

‍

What did DermTech Inc. do wrong?

The complaint alleges that DermTech Inc. falsely advertised its PLA test as a reliable method for detecting skin cancer. The company claimed that the test could identify potential skin cancers with 90.8% accuracy, leading consumers to believe that it was a reliable alternative to traditional biopsies. However, the lawsuit alleges that the test's accuracy rate is significantly lower, putting consumers at risk of misdiagnosis or delayed diagnosis.

‍

How does this affect consumers?

The PLA test is marketed to consumers as a non-invasive, painless way to detect skin cancer early. However, the lawsuit alleges that the test is not as effective as DermTech Inc. claims it to be. As a result, consumers who rely on the test may not receive accurate results, which could lead to delayed or incorrect treatment. This is particularly concerning for individuals who may have melanoma, a deadly form of skin cancer that requires early detection and treatment.

‍

Stand up if you've been affected

Stop Consumer Harm is a secure platform where you can safely report corporate wrongdoing. We are here for you. Let us know what's happened and we will be right there to support you.

Email Address

Tell us your bit of the story

We've successfully received your secure message

Oops! Something went wrong while submitting the form. Please refresh and try again or email us at support@stopconsumerharm.com

‍

Moreover, the lawsuit alleges that DermTech Inc. breached its contract with consumers by failing to provide accurate results. Consumers who paid for the test may have relied on the results, only to discover that they were inaccurate. This is a clear violation of consumer protection laws, which require companies to provide truthful and accurate information about their products and services.

‍

What can consumers do?

If you or someone you know has used DermTech Inc.'s PLA test, it's essential to take action. The first step is to consult with a healthcare professional to determine if the test results were accurate. If the results were inaccurate, you may have grounds for a claim against DermTech Inc.

‍

Additionally, you can join the class action lawsuit filed against DermTech Inc. and others. The lawsuit seeks damages, injunctive relief, restitution, and other forms of compensation for affected consumers. By joining the lawsuit, you can help hold DermTech Inc. accountable for its deceptive practices and ensure that the company takes responsibility for its actions.

‍

Conclusion

In conclusion, the class action lawsuit against DermTech Inc. highlights the dangers of deceptive practices in the healthcare industry. Consumers have the right to expect truthful and accurate information about medical tests and treatments. It's crucial for companies like DermTech Inc. to be held accountable for their actions and ensure that their products and services are safe and effective.

‍

If you or someone you know has been affected by DermTech Inc.'s PLA test, don't hesitate to take action. Join the class action lawsuit and help put an end to deceptive practices in the healthcare industry. Together, we can make a difference and ensure that consumers receive the care and protection they deserve.